Lv71
4678 积分 2022-09-22 加入
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
12天前
已完结
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
12天前
已完结
Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial
18天前
已完结
Pemphigus
18天前
已完结
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
18天前
已完结
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
18天前
已完结
Pemphigus
18天前
已完结
Rituximab: A Review in Pemphigus Vulgaris
18天前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
1个月前
已完结
皖公网安备34019202002308
